Middle East Pharmaceutical Industries Company Intangible Assets

Middle East Pharmaceutical Industries Company posts a intangible assets of $74M as of June 2026. That compares with $54M in the prior-year period — up 37.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Middle East Pharmaceutical Industries Company's intangible assets was $54M. The latest reading is $74M — a 37.3% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Intangible Assets is one piece of Middle East Pharmaceutical Industries Company's financial statement story. At $74M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 4016.SR's intangible assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Middle East Pharmaceutical Industries Company's other metric pages and overview cover the third.